Physician profile
Jennifer S Castro
NPI 1174594709
$2,764.18
in general payments reported to CMS, 2019-2025
33 companies · $230 in 2025
The $230 reported for 2025 was more than what a typical Nurse Practitioner provider received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $878 · 2022: $597 · 2023: $477 · 2024: $583 · 2025: $230.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,289.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,288.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $710.57 | 2021-2025 | |
| Novo Nordisk INC | $388.27 | 2021-2025 | Rybelsus, Ozempic, Wegovy |
| Glaxosmithkline, LLC. | $232.61 | 2021-2024 | Trelegy Ellipta, Shingrix |
| Pfizer INC. | $178.75 | 2021-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $166.32 | 2021-2024 | Xifaxan, Trulance |
| Astellas Pharma US INC | $133.17 | 2021-2024 | Veozah |
| Merck Sharp & Dohme LLC | $109.45 | 2021-2025 | Gardasil 9, Capvaxive, Gardasil |
| Lilly USA, LLC | $95.54 | 2022-2025 | Mounjaro, Zepbound, Jardiance |
| Biofire Diagnostics, LLC | $55.12 | 2021 | |
| Exact Sciences Corporation | $50.46 | 2023-2024 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $49.24 | 2021-2024 | Airsupra |
| Grifols USA, LLC | $47.48 | 2021-2023 | Prolastin-C Liquid |
| Amgen INC. | $45.55 | 2022-2024 | Repatha, Otezla |
| Bayer Healthcare Pharmaceuticals INC. | $43.49 | 2022 | |
| Abbott Laboratories | $43.29 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $38.56 | 2022 | |
| Inspire Medical Systems, INC. | $38.55 | 2024-2025 | Inspire |
| Almatica Pharma LLC | $36.57 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $31.75 | 2022 | |
| Mayne Pharma Commercial LLC | $29.42 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $27.42 | 2021 | |
| Inogen, INC. | $25.91 | 2022-2023 | Inogen One G5 Oxygen Concentrator - Bluetooth |
| Corcept Therapeutics | $21.42 | 2025 | Korlym |
| Genentech USA, INC. | $19.86 | 2021 | |
| Sumitomo Pharma America, INC. | $18.81 | 2025 | Gemtesa |
| Janssen Pharmaceuticals, INC | $18.74 | 2021 | |
| Dynavax Technologies Corporation | $18.46 | 2023 | Heplisav-B |
| Gilead Sciences, INC. | $18.29 | 2023 | |
| Indivior INC. | $16.41 | 2025 | Sublocade |
| Smith+Nephew, INC. | $16.30 | 2023 | Renasys Touch, Renasys Go V2 Home, Pico |
| Boston Scientific Corporation | $14.66 | 2025 | Watchman Flx |
| Ibsa Pharma INC. | $12.02 | 2021 | |
| Amarin Pharma, INC. | $11.72 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jennifer Castro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.